UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051611
Receipt number R000058890
Scientific Title Utility confirmation study on the oral effects of consecutive use of dentifrice NW372
Date of disclosure of the study information 2023/08/01
Last modified on 2023/11/13 15:45:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy test of the dentifrice

Acronym

Efficacy test of the dentifrice

Scientific Title

Utility confirmation study on the oral effects of consecutive use of dentifrice NW372

Scientific Title:Acronym

Efficacy test of the dentifrice

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the oral benefits of continuous use of dentifrice NW372.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Amount of gingival condition before and after 4 weeks of dentifrice use

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Use dentifrice NW372 at least twice a day for 4 weeks

Interventions/Control_2

Use control dentifrice at least twice a day for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

49 years-old >=

Gender

Male

Key inclusion criteria

1.Male of 30 to 49 years of age.
2.Subjects who brush their teeth at least twice a day.
3.Subjects who agreed to use only the test dentifrice and designated toothbrush during the study period.

Key exclusion criteria

1.Subjects with implants, dentures, or false teeth in the anterior maxillary region.
2.Subjects with full denture.
3.Smokers.
4.Subjects who are currently attend a dental clinic.
5.Subjects who are already participating in other research at the time of receiving an explanation of the research, or who are scheduled to participate in other research during the period of cooperation for participation in this study.
6.Subjects who are judged by the principal investigator to be inappropriate to participate in the research due to other reasons such as noncompliance with compliance obligations.

Target sample size

36


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Nakatsu

Organization

Kao Corporation

Division name

Personal health care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9747

Email

nakatsu.susumu@kao.com


Public contact

Name of contact person

1st name Atsuko
Middle name
Last name Chiba

Organization

Kao Corporation

Division name

Personal health care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9747

Homepage URL


Email

chiba.atsuko@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 07 Month 13 Day

Date of IRB

2023 Year 07 Month 13 Day

Anticipated trial start date

2023 Year 08 Month 07 Day

Last follow-up date

2023 Year 10 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 07 Month 14 Day

Last modified on

2023 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058890


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name